Brimonidine Tartrate topical and Novoeight recombinant

• Generic Name: brimonidine topical
• Dosage Forms: n.a.
• Other Brand Names: Mirvaso, Mirvaso Pump

Used topically for the treatment of persistent (nontransient) erythema associated with rosacea (acne rosacea).

Effective in treating erythema, unlike other currently available medications for rosacea (e.g., azelaic acid, doxycycline, metronidazole).

Does not affect the inflammatory lesions associated with rosacea.

• Generic Name: antihemophilic factor
• Dosage Forms: n.a.
• Other Brand Names: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur

Novoeight is a naturally occurring protein in the blood that helps blood to clot. A lack of antihemophilic factor VIII is the cause of hemophilia A. Recombinant this medicine works by temporarily raising levels of factor VIII in the blood to aid in clotting.

Recombinant Novoeight is used to treat or prevent bleeding episodes in adults and children with hemophilia A. It is also used to control bleeding related to surgery or dentistry in a person with hemophilia, and to prevent joint damage in people age 16 or older with severe hemophilia A and no prior joint damage.

Recombinant Novoeight is not for use in people with von Willebrand disease.

Recombinant Novoeight may also be used for purposes not listed in this medication guide.